Skip to content

Clinical trials

Phase 3 Hemorrhagic Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Disorders Phase: Phase 3 Country / region: Germany Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20171
20182
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genzyme, a Sanofi Company2
BioMarin Pharmaceutical1
CTI BioPharma1
Kedrion S.p.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases5
Hemorrhagic Disorders5
Blood Coagulation Disorders4
Blood Coagulation Disorders, Inherited3
Coagulation Protein Disorders3
Genetic Diseases, Inborn3
Hemophilia A3
Genetic Diseases, X-Linked2
Hemophilia B2
Anemia1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.